Expression of Immuoregulators IDO1, and PD-L1 in Gastrointestinal Stromal Tumors

被引：0
|
作者：
Matoso, Andres [1 ]
Siddique, Ayesha [1 ]
Lombardo, Kara A. [1 ]
Resnick, Murray B. [1 ]
Taliano, Ross [1 ]
Wang, Li J. [1 ]
机构：
[1] Brown Univ, Providence, RI 02912 USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
747
引用
收藏
页码：187A / 187A
页数：1
相关论文
共 50 条
  • [11] Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells
    Chen, Yu-Chi
    He, Xin-Ling
    Qi, Lu
    Shi, Wei
    Yuan, Luo-Wei
    Huang, Mu-Yang
    Xu, Yu-Lian
    Chen, Xiuping
    Gu, Lei
    Zhang, Le-Le
    Lu, Jin-Jian
    BIOCHEMICAL PHARMACOLOGY, 2022, 197
  • [12] COMPUTATIONAL ANALYSIS OF MUTUAL FEEDBACK REGULATIONS BETWEEN IDO1 AND PD-L1
    Zhu, Jian
    Zhu, Rebecca
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A401 - A401
  • [13] Co-Expression of IDO1 and PD-L1 Indicates More Aggressive Features of Lung Adenocarcinoma
    Kozuma, Y.
    Takada, K.
    Toyokawa, G.
    Kohashi, K.
    Shimokawa, M.
    Kinoshita, F.
    Matsubara, T.
    Haratake, N.
    Takamori, S.
    Akamine, T.
    Hirai, F.
    Tagawa, T.
    Oda, Y.
    Maehara, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1781 - S1781
  • [14] Immune Cell Infiltration and the Expression of PD-1 and PD-L1 in Primary PDGFRA-Mutant Gastrointestinal Stromal Tumors
    Sun, Xiangfei
    Sun, Jianyi
    Yuan, Wei
    Gao, Xiaodong
    Fu, Min
    Xue, Anwei
    Li, He
    Shu, Ping
    Fang, Yong
    Hou, Yingyong
    Shen, Kuntang
    Sun, Yihong
    Qin, Jing
    Qin, Xinyu
    JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (08) : 2091 - 2100
  • [15] Immune Cell Infiltration and the Expression of PD-1 and PD-L1 in Primary PDGFRA-Mutant Gastrointestinal Stromal Tumors
    Xiangfei Sun
    Jianyi Sun
    Wei Yuan
    Xiaodong Gao
    Min Fu
    Anwei Xue
    He Li
    Ping Shu
    Yong Fang
    Yingyong Hou
    Kuntang Shen
    Yihong Sun
    Jing Qin
    Xinyu Qin
    Journal of Gastrointestinal Surgery, 2021, 25 : 2091 - 2100
  • [16] PD-L1, MMR, and EGFR expression in gastrointestinal neuroendocrine tumors
    Karabag, Sevil
    Oznur, Meltem
    CUKUROVA MEDICAL JOURNAL, 2024, 49 (02): : 400 - 406
  • [17] PD-L1 and IDO1 expression and clinical outcome in 305 patients with surgically resected esophageal cancer.
    Baba, Yoshifumi
    Ishimoto, Takatsugu
    Hiyoshi, Yukiharu
    Iwatsuki, Masaaki
    Miyamoto, Yuji
    Yoshida, Naoya
    Baba, Hideo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [18] Overall Survival by IDO1 and PD-L1 Expression in NSCLC Patients Receiving an Immune Checkpoint Inhibitor (ICI)
    Moore, M.
    Hall, R.
    Mcloughlin, E.
    Melson, J.
    Horton, B.
    Mills, A.
    Gentzler, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S738 - S738
  • [19] PD-L1 Immunostaining in Patients with Recurrent and Metastatic Gastrointestinal Stromal Tumors (GIST)
    Crystal, J. S.
    Makhoul, E.
    Cox, B.
    Balzer, B.
    Gangi, A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S39 - S39
  • [20] Association of PD-L1 and IDO1 expression with JAK-STAT pathway activation in soft-tissue leiomyosarcoma
    Iwasaki, Takeshi
    Kohashi, Kenichi
    Toda, Yu
    Ishihara, Shin
    Yamada, Yuichi
    Oda, Yoshinao
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (05) : 1451 - 1463
12345